(Q39509938)

12 September 2017

Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study (English)

1 reference

12 September 2017

1 reference

1 reference

8

Anne Tjønneland

1 reference

12 September 2017

5

Henrik Toft Sørensen

0 references

Signe Benzon Larsen

object named as

Signe Benzon Larsen

7

0 references

Christian Dehlendorff

object named as

Christian Dehlendorff

2

0 references

Jesper Hallas

6

object named as

Jesper Hallas

1 reference

12 September 2017

Charlotte Skriver

1

1 reference

12 September 2017

Michael Borre

3

1 reference

12 September 2017

Klaus Brasso

4

1 reference

12 September 2017

Søren Friis

9

1 reference

12 September 2017

9 August 2016

1 reference

12 September 2017

Cancer Causes & Control

1 reference

12 September 2017

27

1 reference

12 September 2017

9

1 reference

12 September 2017

1067-1079

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-016-0785-7

12 September 2017

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Prevention and early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Risk factors for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Estimates of benefits and harms of prophylactic use of aspirin in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The role of aspirin in cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin and colorectal cancer: the promise of precision chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Non-steroidal anti-inflammatory drugs (NSAIDs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin and urologic cancer risk: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Nonsteroidal anti-inflammatory drugs and prostate cancer risk in the VITamins And Lifestyle (VITAL) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Risk of prostate cancer in low-dose aspirin users: A retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

When the entire population is the sample: strengths and limitations in register-based epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish Civil Registration System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish Civil Registration System as a tool in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish Pathology Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish National Prescription Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The Danish National Patient Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Danish Education Registers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Danish registers on personal income and transfer payments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Cancer risk among users of neuroleptic medication: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Completeness of prostate cancer staging in the Danish Cancer Registry, 2004-2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: findings from a large, population-based, case-control study (the ProtecT study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Prostate cancer in Denmark 1978-2009--trends in incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

Diabetes and Outcome of Community-Acquired Pneumococcal Bacteremia: A 10-year population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-016-0785-7

10.1007/S10552-016-0785-7

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference